Celularity Inc
CELU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001752828
No open-market purchases or sales by Celularity Inc insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $2.44M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Celularity Inc as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +21 vs. Q2 2021
- Shares held
- 1.19M
- +1.19M vs. Q2 2021
- Total value
- $8.42M
- +$8.42M vs. Q2 2021
- New holders
- 21
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CELU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $2.44M |
| Q1 2026 | 38 | $2.88M |
| Q4 2025 | 36 | $3.19M |
| Q3 2025 | 38 | $4.76M |
| Q2 2025 | 34 | $4.27M |
| Q1 2025 | 29 | $3.43M |
| Q4 2024 | 32 | $3.85M |
| Q3 2024 | 27 | $2.86M |
| Q2 2024 | 26 | $2.96M |
| Q1 2024 | 30 | $4.38M |
| Q4 2023 | 37 | $2.05M |
| Q3 2023 | 45 | $8.02M |
| Q2 2023 | 56 | $18.8M |
| Q1 2023 | 61 | $21.3M |
| Q4 2022 | 73 | $44.2M |
| Q3 2022 | 72 | $81.0M |
| Q2 2022 | 66 | $105.1M |
| Q1 2022 | 37 | $232.0M |
| Q4 2021 | 25 | $85.6M |
| Q3 2021 | 21 | $8.42M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Celularity Inc; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Valley National Advisers Inc | 1,000 | $7.00K | 0.00% | +1,000 | New |
| Harbour Investments, Inc. | 1,200 | $8.00K | 0.00% | +1,200 | New |
| Citigroup Inc | 1,449 | $10.0K | 0.00% | +1,449 | New |
| Bank of America Corp | 2,223 | $16.0K | 0.00% | +2,223 | New |
| Captrust Financial Advisors | 3,000 | $21.0K | 0.00% | +3,000 | New |
| UBS Group AG | 2,898 | $21.0K | 0.00% | +2,898 | New |
| Cutler Group LP | 9,743 | $68.0K | 0.01% | +9,743 | New |
| Marshall Wace, LLP | 12,291 | $87.0K | 0.00% | +12,291 | New |
| Penserra Capital Management LLC | 12,566 | $88.0K | 0.00% | +12,566 | New |
| Millennium Management LLC | 15,385 | $109.0K | 0.00% | +15,385 | New |
| Caption Management, LLC | 20,000 | $142.0K | 0.01% | +20,000 | New |
| Group One Trading, L.P. | 21,249 | $150.0K | 0.00% | +21,249 | New |
| BlackRock Inc. | 25,305 | $179.0K | 0.00% | +25,305 | New |
| Jane Street Group, LLC | 30,636 | $217.0K | 0.00% | +30,636 | New |
| Citadel Advisors LLC | 33,474 | $237.0K | 0.00% | +33,474 | New |
| Lombard Odier Asset Management (USA) Corp | 40,000 | $283.0K | 0.04% | +40,000 | New |
| Verition Fund Management LLC | 50,000 | $354.0K | 0.01% | +50,000 | New |
| Morgan Stanley | 51,000 | $361.0K | 0.00% | +51,000 | New |
| Geode Capital Management, LLC | 66,554 | $471.0K | 0.00% | +66,554 | New |
| HRT Financial LP | 144,837 | $1.02M | 0.01% | +144,837 | New |
| FMR LLC | 644,600 | $4.56M | 0.00% | +644,600 | New |